Use of statins in lower extremity artery disease: a review
Authors:
- Giuseppe GargiuloGiuseppe Gargiulo
- Giuseppe GiuglianoGGGiuseppe Giugliano
- Linda BrevettiLBLinda Brevetti
- Anna SanninoASAnna Sannino
- Gabriele Giacomo SchiattarellaGSGabriele Giacomo Schiattarella
- Federica SerinoFSFederica Serino
- Andreina CarboneACAndreina Carbone
- Fernando ScudieroFSFernando Scudiero
- Marco FerroneMFMarco Ferrone
- Roberto CorradoRCRoberto Corrado
- Raffaele IzzoRIRaffaele Izzo
- Lorenzo ChiariottiLorenzo Chiariotti
Open Access
- 15 November 2012
- journal article
- review article
- Published by Springer Nature in BMC Surgery
- Vol. 12 (S1) , S15
Abstract
Background: Lower extremity artery disease (LE-PAD) is one of the most common manifestations of atherosclerosis, particularly in elderly patients, and it is related to a high cardiovascular risk. Description: It is well established that statin therapy is characterized by crucial benefits on cardiovascular system by limiting atherosclerotic progression and reducing cardiovascular events and mortality. A growing body of evidence support efficacy of statins in LE-PAD due to the ability of both reducing cardiovascular risk and improving walking distance and, hence, quality of life. Consequently, statin therapy should be considered in all LE-PAD patients and new LDL-cholesterol targets should be reached. Conclusions: Our opinion is that statin therapy remains still underutilized or with inadequate dosage, so therapy of LE-PAD patients should be improved to obtain all the demonstrated benefits of statins.Keywords
This publication has 25 references indexed in Scilit:
- Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial diseaseInternational Journal of Cardiology, 2013
- Femoral Plaque Echogenicity and Cardiovascular Risk in ClaudicantsJACC: Cardiovascular Imaging, 2012
- ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)European Heart Journal, 2011
- Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settingsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial DiseaseJACC, 2006
- Statin therapy improves cardiovascular outcome of patients with peripheral artery diseaseEuropean Heart Journal, 2004
- Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drugThe American Journal of Cardiology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: A report from the regression growth evaluation statin studyThe American Journal of Cardiology, 1995
- An Accurate Stepwise Electrocardiographic Algorithm for localization of Accessory Pathways in Patients With Wolff-Parkinson-White Syndrome from a Comprehensive Analysis of Delta Waves and R/S Ratio During Sinus RhythmThe American Journal of Cardiology, 1995